Misplaced Pages

Hidrosmin: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 04:33, 2 September 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID|Chem/Drugbox va← Previous edit Latest revision as of 15:10, 10 April 2023 edit undoJ04n (talk | contribs)Autopatrolled, Administrators162,685 editsm Checkwiki error fix #3 Reference list missing 
(12 intermediate revisions by 11 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| Verifiedfields = changed
| Watchedfields = changed | Watchedfields = changed
| verifiedrevid = 424723071 | verifiedrevid = 447983508
| IUPAC_name = <small>5-(2-hydroxyethoxy)-2-(3-hydroxy-4-methoxyphenyl)-7-oxymethyl]oxan-2-yl]oxychromen-4-one</small> | IUPAC_name = <small>5-(2-hydroxyethoxy)-2-(3-hydroxy-4-methoxyphenyl)-7-oxymethyl]oxan-2-yl]oxychromen-4-one</small>
| image = Hidrosmin.png | image = Hidrosmin.svg


<!--Clinical data--> <!--Clinical data-->
Line 16: Line 18:
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = | legal_status =
| routes_of_administration = | routes_of_administration =


<!--Pharmacokinetic data--> <!--Pharmacokinetic data-->
Line 23: Line 25:
| metabolism = | metabolism =
| elimination_half-life = | elimination_half-life =
| excretion = | excretion =


<!--Identifiers--> <!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 115960-14-0 | CAS_number = 115960-14-0
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4I5K8199OQ
| ATC_prefix = C05 | ATC_prefix = C05
| ATC_suffix = CA05 | ATC_suffix = CA05
Line 32: Line 37:
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = | DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 2344126
| smiles = O=C\4c5c(OCCO)cc(O2O(CO1O((O)(O)1O)C)(O)(O)2O)cc5O/C(c3ccc(OC)c(O)c3)=C/4
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C30H36O16/c1-12-23(34)25(36)27(38)29(43-12)42-11-21-24(35)26(37)28(39)30(46-21)44-14-8-19(41-6-5-31)22-16(33)10-18(45-20(22)9-14)13-3-4-17(40-2)15(32)7-13/h3-4,7-10,12,21,23-32,34-39H,5-6,11H2,1-2H3/t12-,21+,23-,24+,25+,26-,27+,28+,29+,30+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = XYFLWVOTXWXNAM-WTNNCJBMSA-N


<!--Chemical data--> <!--Chemical data-->
| C=30 | H=36 | O=16 | C=30 | H=36 | O=16
| molecular_weight = 652.59724 g/mol
| synonyms = Venosmil<br>O-(beta-])] | synonyms = Venosmil<br>O-(beta-])]
}} }}


'''Hidrosmin''' is a ], a type of flavonoid. It is a ].<ref name="pmid1633720">{{cite journal | vauthors = Domínguez C, Brautigam I, González E, González JA, Nazco J, Valiente R, Boada J | title = Therapeutic effects of hidrosmin on chronic venous insufficiency of the lower limbs | journal = Current Medical Research and Opinion | volume = 12 | issue = 10 | pages = 623–30 | date = 1992 | pmid = 1633720 | doi = 10.1185/03007999209111529 }}</ref>
'''Hidrosmin''' is a ], a type of flavonoid. It is a ].


==References==
{{reflist}}


{{Flavone}} {{Flavone}}
{{Vasoprotectives}} {{Vasoprotectives}}


] ]
]
] ]



{{cardiovascular-drug-stub}} {{cardiovascular-drug-stub}}

Latest revision as of 15:10, 10 April 2023

Chemical compound Pharmaceutical compound
Hidrosmin
Clinical data
Other namesVenosmil
O-(beta-Hydroxyethyl)diosmin
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
IUPAC name
  • 5-(2-hydroxyethoxy)-2-(3-hydroxy-4-methoxyphenyl)-7-oxymethyl]oxan-2-yl]oxychromen-4-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC30H36O16
Molar mass652.602 g·mol
3D model (JSmol)
SMILES
  • O=C\4c5c(OCCO)cc(O2O(CO1O((O)(O)1O)C)(O)(O)2O)cc5O/C(c3ccc(OC)c(O)c3)=C/4
InChI
  • InChI=1S/C30H36O16/c1-12-23(34)25(36)27(38)29(43-12)42-11-21-24(35)26(37)28(39)30(46-21)44-14-8-19(41-6-5-31)22-16(33)10-18(45-20(22)9-14)13-3-4-17(40-2)15(32)7-13/h3-4,7-10,12,21,23-32,34-39H,5-6,11H2,1-2H3/t12-,21+,23-,24+,25+,26-,27+,28+,29+,30+/m0/s1
  • Key:XYFLWVOTXWXNAM-WTNNCJBMSA-N
  (what is this?)  (verify)

Hidrosmin is a flavone, a type of flavonoid. It is a vasoprotective.

References

  1. Domínguez C, Brautigam I, González E, González JA, Nazco J, Valiente R, Boada J (1992). "Therapeutic effects of hidrosmin on chronic venous insufficiency of the lower limbs". Current Medical Research and Opinion. 12 (10): 623–30. doi:10.1185/03007999209111529. PMID 1633720.
Flavones and their conjugates
Aglycones
Monohydroxyflavone
Dihydroxyflavones
Trihydroxyflavones
Tetrahydroxyflavones
Pentahydroxyflavones
O-methylated flavones
Glycosides
of apigenin
of baicalein
of hypolaetin
of luteolin
Acetylated
  • Artocarpetin A
  • Artoindonesianin P
  • Sulfated glycosidesTheograndin I and II
    Polymers
    Drugs
    Vasoprotectives (C05)
    Antihemorrhoidals for topical use
    corticosteroids
    local anesthetics
    other
    Antivaricose therapy
    heparins or heparinoids for topical use
    sclerosing agents for local injection
    other
    Capillary stabilising agents
    bioflavonoids
    other


    Stub icon

    This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

    Categories: